24 February 2019 - Australians with advanced bladder cancer may be able to access a drug to be subsidised nationally, with the drug also used to treat other cancers.
Australians battling bladder cancer will be able to access a drug to be subsided on the national Pharmaceutical Benefits Scheme to treat the life-threatening illness.
Federal Health Minister Greg Hunt is will announce on Sunday the price of immunotherapy, Keytruda, will be subsidised from March 1 for patients with advanced cancer which develops in the bladder and cannot be controlled by chemotherapy.